• Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

  • Feb 6 2024
  • Duración: 12 m
  • Podcast

Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.

    Related Content:

    • Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years
    Más Menos
Más Menos

Lo que los oyentes dicen sobre Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles